AR230178A1 - Procedimiento para preparar composiciones farmaceuticas - Google Patents

Procedimiento para preparar composiciones farmaceuticas

Info

Publication number: AR230178A1
Authority: AR; Argentina
Prior art keywords: procedure; pharmaceutical compositions; preparing pharmaceutical; preparing; compositions
Prior art date: 1979-06-22

Application number

AR281473A

Other languages

English (en)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-06-22

Filing date

1980-06-19

Publication date

1984-03-01

1980-06-19 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1984-03-01 Application granted granted Critical

1984-03-01 Publication of AR230178A1 publication Critical patent/AR230178A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dispersion Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AR281473A 1979-06-22 1980-06-19 Procedimiento para preparar composiciones farmaceuticas AR230178A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH586379		1979-06-22

Publications (1)

Publication Number	Publication Date
AR230178A1 true AR230178A1 (es)	1984-03-01

Family

ID=4300559

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AR281473A AR230178A1 (es)	1979-06-22	1980-06-19	Procedimiento para preparar composiciones farmaceuticas

Country Status (21)

Country	Link
US (1)	US4411894A (es)
EP (1)	EP0021337B1 (es)
JP (1)	JPS567714A (es)
KR (1)	KR850001301B1 (es)
AR (1)	AR230178A1 (es)
AT (1)	ATE5508T1 (es)
AU (1)	AU534959B2 (es)
CA (1)	CA1173360A (es)
DE (1)	DE3065818D1 (es)
DK (1)	DK155172C (es)
ES (1)	ES8104720A1 (es)
FI (1)	FI72875C (es)
HU (1)	HU186296B (es)
IE (1)	IE49615B1 (es)
IL (1)	IL60326A (es)
MC (1)	MC1336A1 (es)
NO (1)	NO155226C (es)
NZ (1)	NZ194047A (es)
PH (1)	PH16795A (es)
PT (1)	PT71436B (es)
ZA (1)	ZA803567B (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59152348A (ja) *	1983-02-19	1984-08-31	Kaken Pharmaceut Co Ltd	ビフエニリルプロピオン酸エステル誘導体およびその製造法
US5186941A (en) *	1983-05-06	1993-02-16	Vestar, Inc.	Vesicle formulation for the controlled release of therapeutic agents
JPH0768117B2 (ja) *	1983-05-06	1995-07-26	ベスター・インコーポレイテツド	薬剤放出調整用小胞製剤
CA1237670A (en) *	1983-05-26	1988-06-07	Andrew S. Janoff	Drug preparations of reduced toxicity
US5059591B1 (en) *	1983-05-26	2000-04-25	Liposome Co Inc	Drug preparations of reduced toxicity
JPS601122A (ja) *	1983-06-20	1985-01-07	Green Cross Corp:The	ビフエニリルプロピオン酸誘導体脂肪乳剤
CA1264162A (en) *	1984-03-15	1990-01-02	Manfred Breuninger	Glycerol ether phosphatides
JPS60208910A (ja) *	1984-03-31	1985-10-21	Green Cross Corp:The	水難溶性薬物・リン脂質複合体の製造方法
US5231112A (en)	1984-04-12	1993-07-27	The Liposome Company, Inc.	Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US4891208A (en) *	1985-04-10	1990-01-02	The Liposome Company, Inc.	Steroidal liposomes
PT78628B (en) *	1984-05-02	1986-06-18	Liposome Co Inc	Pharmaceutical composition with reduced toxicity
CA1264668A (en) *	1984-06-20	1990-01-23	Pieter R. Cullis	Extrusion techniques for producing liposomes
US5077056A (en) *	1984-08-08	1991-12-31	The Liposome Company, Inc.	Encapsulation of antineoplastic agents in liposomes
US5736155A (en) *	1984-08-08	1998-04-07	The Liposome Company, Inc.	Encapsulation of antineoplastic agents in liposomes
US4880635B1 (en) *	1984-08-08	1996-07-02	Liposome Company	Dehydrated liposomes
CA1270198C (en) *	1984-08-08	1990-06-12	Marcel B Bally	ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
JPS61100518A (ja) *	1984-10-22	1986-05-19	Ono Pharmaceut Co Ltd	ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
US4857319A (en) *	1985-01-11	1989-08-15	The Regents Of The University Of California	Method for preserving liposomes
JPS62501631A (ja) *	1985-01-11	1987-07-02	ザ・リ−ジェンツ・オブ・ジ・ユニバ−シィティ・オブ・カリフォルニア	リポソ−ムの保持法
US4753788A (en) *	1985-01-31	1988-06-28	Vestar Research Inc.	Method for preparing small vesicles using microemulsification
CA1256372A (en) *	1985-04-11	1989-06-27	Koichiro Miyazima	Process for producing liposome composition
US5409704A (en) *	1985-06-26	1995-04-25	The Liposome Company, Inc.	Liposomes comprising aminoglycoside phosphates and methods of production and use
IL79114A (en) *	1985-08-07	1990-09-17	Allergan Pharma	Method and composition for making liposomes
US5622713A (en) *	1985-09-17	1997-04-22	The Regents Of The University Of California	Method of detoxifying animal suffering from overdose
US4766046A (en) *	1985-09-27	1988-08-23	Liposome Technology, Inc.	Stabilized liposome/amphotericin composition and method
IE58981B1 (en) *	1985-10-15	1993-12-15	Vestar Inc	Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
US5041278A (en) *	1985-10-15	1991-08-20	The Liposome Company, Inc.	Alpha tocopherol-based vesicles
US4861580A (en) *	1985-10-15	1989-08-29	The Liposome Company, Inc.	Composition using salt form of organic acid derivative of alpha-tocopheral
SE8505047L (sv) *	1985-10-25	1987-04-26	Nutritional Int Res Inst	Fettemulsion
US4806343A (en) *	1986-03-13	1989-02-21	University Of Southwestern Louisiana	Cryogenic protectant for proteins
US5252263A (en) *	1986-06-16	1993-10-12	The Liposome Company, Inc.	Induction of asymmetry in vesicles
MX9203808A (es) *	1987-03-05	1992-07-01	Liposome Co Inc	Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4950432A (en) *	1987-10-16	1990-08-21	Board Of Regents, The University Of Texas System	Polyene microlide pre-liposomal powders
US4946683A (en) *	1987-11-18	1990-08-07	Vestar, Inc.	Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
ATE107502T1 (de) *	1988-10-05	1994-07-15	Vestar Inc	Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
US5246707A (en) *	1990-04-26	1993-09-21	Haynes Duncan H	Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
US5091187A (en) *	1990-04-26	1992-02-25	Haynes Duncan H	Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5091188A (en) *	1990-04-26	1992-02-25	Haynes Duncan H	Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
HK1007497A1 (en) *	1990-07-31	1999-04-16	利普索姆公司	Accumulations of amino acids and peptides into liposomes
US5462740A (en) *	1993-09-17	1995-10-31	Athena Neurosciences, Inc.	Rectally-administered, epileptic-seizure-inhibiting composition
US5840328A (en) *	1994-01-11	1998-11-24	The Liposome Company, Inc.	Treatment using arachidonic acid metabolite and particulate formulations
WO1996009037A1 (en) *	1994-09-23	1996-03-28	The Liposome Company, Inc.	Method of producing a lyophilized liposome product
FR2733151B1 (fr) *	1995-04-20	1997-05-23	Seppic Sa	Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6117432A (en) *	1995-04-20	2000-09-12	Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.)	Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6689370B1 (en)	1995-04-20	2004-02-10	Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.)	Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US20040208922A1 (en) *	1995-06-07	2004-10-21	The Regents Of The University Of California	Method for loading lipid like vesicles with drugs or other chemicals
ATE386506T1 (de) *	1995-10-17	2008-03-15	Jagotec Ag	Verabreichung unlöslicher arzneistoffe
GB9609779D0 (en)	1996-05-10	1996-07-17	Univ Bruxelles	Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
US6465016B2 (en)	1996-08-22	2002-10-15	Research Triangle Pharmaceuticals	Cyclosporiine particles
US7255877B2 (en)	1996-08-22	2007-08-14	Jagotec Ag	Fenofibrate microparticles
US5827532A (en) *	1997-01-31	1998-10-27	The Reagents Of The University Of California	Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
IT1289938B1 (it) *	1997-02-20	1998-10-19	Angelini Ricerche Spa	Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
US6037323A (en)	1997-09-29	2000-03-14	Jean-Louis Dasseux	Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en)	1997-09-29	2000-04-04	Jean-Louis Dasseux	Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6518412B1 (en) *	1997-09-29	2003-02-11	Jean-Louis Dasseux	Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en)	1997-09-29	1999-12-21	J. L. Dasseux	Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6287590B1 (en) *	1997-10-02	2001-09-11	Esperion Therapeutics, Inc.	Peptide/lipid complex formation by co-lyophilization
CN1289091C (zh) *	1998-02-11	2006-12-13	Rtp药品公司	治疗炎症的药物组合物和相关用途
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
WO1999061001A1 (en)	1998-05-29	1999-12-02	Rtp Pharma Inc.	Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
CA2338703C (en)	1998-08-19	2009-03-24	Rtp Pharma Inc.	Injectable aqueous dispersions of propofol
SK288117B6 (sk)	1998-11-20	2013-09-03	Skyepharma Canada Inc.	Rapidly dispersing solid dry therapeutic dosage form
EP1276465B1 (en)	2000-04-20	2014-03-12	Jagotec AG	Improved water-insoluble drug particle process
US6653062B1 (en) *	2000-07-26	2003-11-25	Wisconsin Alumni Research Foundation	Preservation and storage medium for biological materials
EP1313451B1 (en)	2000-08-31	2009-03-11	Jagotec AG	Milled particles
US8586094B2 (en)	2000-09-20	2013-11-19	Jagotec Ag	Coated tablets
KR100869824B1 (ko) *	2000-11-09	2008-11-21	네오팜 인코포레이티드	Ｓｎ-38 지질 복합체 및 사용 방법
ES2284646T3 (es) *	2001-02-22	2007-11-16	Jagotec Ag	Combinaciones de estatina-fibrato con efectos secundarios en ayunas-alimentado reducidos.
WO2003030864A1 (en)	2001-05-29	2003-04-17	Neopharm, Inc.	Liposomal formulation of irinotecan
WO2004035032A2 (en) *	2002-08-20	2004-04-29	Neopharm, Inc.	Pharmaceutical formulations of camptothecine derivatives
KR100651728B1 (ko) *	2004-11-10	2006-12-06	한국전자통신연구원	정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
CA2503087A1 (en) *	2005-03-30	2006-09-30	Medicure International Inc.	Intravenous formulations of pyridoxal 5'-phosphate and method of preparation
CA2653840A1 (en) *	2006-06-01	2007-12-06	Institut De Cardiologie De Montreal	Use of a peptide/phospholipid complex acting as a reverse lipid transport agonist for treatment of valvular stenosis
EP2939683B1 (en) *	2009-02-16	2017-01-04	Cerenis Therapeutics Holding SA	Apolipoprotein A-I Mimics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2081586A2 (en) *	1970-01-24	1971-12-10	Orsymonde	Dehydrated pharmaceutical comps by - lyophilisation
JPS5186117A (en) *	1975-01-27	1976-07-28	Tanabe Seiyaku Co	Johoseibiryushiseizainoseiho
IT1202370B (it) *	1976-07-12	1989-02-09	Hoffmann La Roche	Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
DE2656333C2 (de) *	1976-12-13	1985-08-08	Karl Prof. Dr.med. 7302 Ostfildern Theurer	Verfahren zur Herstellung von Liposomen, welche Arzneistoffe enthalten
GB1575343A (en) *	1977-05-10	1980-09-17	Ici Ltd	Method for preparing liposome compositions containing biologically active compounds
CH621479A5 (es) *	1977-08-05	1981-02-13	Battelle Memorial Institute

1980
- 1980-06-09 CA CA000353627A patent/CA1173360A/en not_active Expired
- 1980-06-11 FI FI801876A patent/FI72875C/fi not_active IP Right Cessation
- 1980-06-13 NZ NZ194047A patent/NZ194047A/xx unknown
- 1980-06-13 AU AU59289/80A patent/AU534959B2/en not_active Ceased
- 1980-06-16 ZA ZA00803567A patent/ZA803567B/xx unknown
- 1980-06-16 IL IL60326A patent/IL60326A/xx unknown
- 1980-06-18 HU HU801512A patent/HU186296B/hu not_active IP Right Cessation
- 1980-06-18 DE DE8080103395T patent/DE3065818D1/de not_active Expired
- 1980-06-18 AT AT80103395T patent/ATE5508T1/de not_active IP Right Cessation
- 1980-06-18 EP EP80103395A patent/EP0021337B1/de not_active Expired
- 1980-06-19 AR AR281473A patent/AR230178A1/es active
- 1980-06-19 JP JP8221780A patent/JPS567714A/ja active Pending
- 1980-06-20 DK DK266680A patent/DK155172C/da not_active IP Right Cessation
- 1980-06-20 IE IE1281/80A patent/IE49615B1/en unknown
- 1980-06-20 PT PT71436A patent/PT71436B/pt unknown
- 1980-06-20 MC MC801456A patent/MC1336A1/fr unknown
- 1980-06-20 NO NO801863A patent/NO155226C/no unknown
- 1980-06-20 PH PH24172A patent/PH16795A/en unknown
- 1980-06-21 KR KR1019800002458A patent/KR850001301B1/ko not_active Expired
- 1980-06-21 ES ES492676A patent/ES8104720A1/es not_active Expired
1981
- 1981-08-17 US US06/293,587 patent/US4411894A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO155226C (no)	1987-03-04
EP0021337A2 (de)	1981-01-07
ES492676A0 (es)	1981-05-16
DK155172C (da)	1989-09-18
EP0021337A3 (en)	1981-04-22
AU534959B2 (en)	1984-02-23
IL60326A (en)	1983-09-30
PH16795A (en)	1984-02-28
IE49615B1 (en)	1985-10-30
HU186296B (en)	1985-07-29
FI72875C (fi)	1987-08-10
MC1336A1 (fr)	1981-04-21
IL60326A0 (en)	1980-09-16
NO801863L (no)	1980-12-22
NO155226B (no)	1986-11-24
PT71436A (en)	1980-07-01
CA1173360A (en)	1984-08-28
AU5928980A (en)	1981-01-08
JPS567714A (en)	1981-01-27
EP0021337B1 (de)	1983-12-07
ES8104720A1 (es)	1981-05-16
DK155172B (da)	1989-02-27
FI801876A7 (fi)	1980-12-23
IE801281L (en)	1980-12-22
DK266680A (da)	1980-12-23
KR830002327A (ko)	1983-05-28
DE3065818D1 (en)	1984-01-12
ZA803567B (en)	1981-06-24
PT71436B (en)	1981-10-23
US4411894A (en)	1983-10-25
NZ194047A (en)	1982-09-14
FI72875B (fi)	1987-04-30
ATE5508T1 (de)	1983-12-15
KR850001301B1 (ko)	1985-09-12

Publication	Publication Date	Title
AR230178A1 (es)	1984-03-01	Procedimiento para preparar composiciones farmaceuticas
IT1143089B (it)	1986-10-22	Procedimento per preparare composizioni farmaceutiche attivate
AR231131A1 (es)	1984-09-28	Procedimiento para preparar acilureidoalquil-bencensulfonilureas
ES492943A0 (es)	1981-05-16	Procedimiento para preparar polieteres sililados
ES497884A0 (es)	1982-11-01	Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
ES494352A0 (es)	1981-04-16	Procedimiento para preparar derivados de acidos quinolina- carboxilicos
MX5880E (es)	1984-08-16	Procedimiento para preparar derivados de bencilimidazol
ES492255A0 (es)	1981-06-01	Procedimiento para preparar aroilimidazol-2-onas
ES488635A0 (es)	1980-12-16	Procedimiento para preparar derivados de pirimidina
ES494119A0 (es)	1981-08-01	Procedimiento para preparar derivados de 3-aminoproxiarilo
AR231635A1 (es)	1985-01-31	Procedimiento para preparar acidos azabiciclicos
MX6816E (es)	1986-08-05	Procedimiento para preparar quinolonas
AR229084A1 (es)	1983-06-15	Procedimiento para preparar composiciones de contraste para angiografia
ES488772A0 (es)	1981-02-16	Procedimiento para preparar derivados de pirimidona
MX7642E (es)	1990-05-16	Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
ES489689A0 (es)	1981-02-16	Procedimiento para preparar compuestos de isotiourea
ES495404A0 (es)	1981-09-01	Procedimiento para preparar esteres
MX6141E (es)	1984-11-23	Procedimiento para preparar acil-ureas
MX6024E (es)	1984-09-24	Procedimiento para preparar 2-cloro-4-hidroximetil-tiazoles-5-substituidos
ES493499A0 (es)	1981-07-01	Procedimiento para preparar compuestos de 3-metilemazetidina
MX6405E (es)	1985-05-28	Procedimiento para preparar tiazolilideno-oxo-propionitrilos
MX6971E (es)	1987-01-09	Procedimiento para preparar derivados de tetrahidroquinolina
ES492394A0 (es)	1981-06-01	Procedimiento para preparar derivados de pirimidina
ES496518A0 (es)	1982-04-01	Procedimiento para preparar bencil-oximeteres trisustituidos
ES492692A0 (es)	1981-06-01	Procedimiento para preparar derivados de benoimidazol